SAMHD1 is a triphosphate hydrolase that specifically deactivates the AzadC triphosphate, but not the AzaC triphosphate and is therefore one of the reasons why some AML subtypes do not respond to AzadC [30]. Here, SAMHD1 is linked to acute myeloid leukemia.